NCT00595374 - Efficacy and Safety of Insulin Detemir in Type 1 Diabetes | Biotech Hunter

Enrollment

114

Participants

Timeline

Start Date

December 2, 2003

Primary Completion Date

October 7, 2004

Study Completion Date

October 7, 2004

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

insulin detemir

DRUG

insulin NPH

DRUG

insulin aspart

Trial Locations (18)

3818 ES

Novo Nordisk Investigational Site, Amersfoort

7334 DZ

Novo Nordisk Investigational Site, Apeldoorn

1782 GZ

Novo Nordisk Investigational Site, Den Helder

7415 CM

Novo Nordisk Investigational Site, Deventer

7511 JX

Novo Nordisk Investigational Site, Enschede

2805 AH

Novo Nordisk Investigational Site, Gouda

7909 AA

Novo Nordisk Investigational Site, Hoogeveen

2262 BA

Novo Nordisk Investigational Site, Leidschendam

7943 KA

Novo Nordisk Investigational Site, Meppel

3083 AN

Novo Nordisk Investigational Site, Rotterdam

9501 EH

Novo Nordisk Investigational Site, Stadskanaal

2566 MJ

Novo Nordisk Investigational Site, The Hague

2597 AX

Novo Nordisk Investigational Site, The Hague

3563 AZ

Novo Nordisk Investigational Site, Utrecht

5141 BM

Novo Nordisk Investigational Site, Waalwijk

6001 BE

Novo Nordisk Investigational Site, Weert

6903 ZN

Novo Nordisk Investigational Site, Zevenaar

8025 AB

Novo Nordisk Investigational Site, Zwolle